n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with iproniazid in 1 studies
| Studies (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Trials (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Recent Studies (post-2010) (n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine) | Studies (iproniazid) | Trials (iproniazid) | Recent Studies (post-2010) (iproniazid) |
|---|---|---|---|---|---|
| 25 | 0 | 12 | 1,785 | 8 | 82 |
| Protein | Taxonomy | n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine (IC50) | iproniazid (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 6.85 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 7.97 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 7.5 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 5 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 5.7032 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 5.9633 | |
| C-X-C chemokine receptor type 3 | Homo sapiens (human) | 6.56 | |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 7.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and iproniazid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |